Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.21 HKD | -0.38% | +0.39% | -21.54% |
02/05 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
10/04 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
- Stock Market
- Equities
- 9966 Stock
- News Alphamab Oncology
- MarketScreener Editorial Features